Fig. 8: Correlation of PRMT1 expression with ME2 methylation and clinical prognosis of HCC. | Cell Death & Disease

Fig. 8: Correlation of PRMT1 expression with ME2 methylation and clinical prognosis of HCC.

From: PRMT1-mediated methylation of ME2 promotes hepatocellular carcinoma growth by inhibiting ubiquitination

Fig. 8

A–C Immunohistochemical staining assay of the methylation levels of PRMT1 (A), ME2 (B), and ME2 expression in 73 paired human paracarcinomas, primary foci, and metastatic foci. D, K Images of immunohistochemical analysis of the expression levels of PRMT1, ME2, and ME2-R67K. E–G Correlation of PRMT1 (E), ME2 (F), ME2-R67K (G) in HCC tissues analyzed after immunohistochemical scoring. H–J. Cardinality analysis of expression correlation of PRMT1 (H), ME2 (I), ME2-R67K (J) after post immunohistochemical scoring. L, M Cardinality analysis of correlation between ME2-R67K expression and tumor size (L) and tumor pathological grade (M). N, O Survival analysis of association between ME2-R67K expression and prognosis of HCC patients.

Back to article page